Wilson Mark Andrew
Chief Legal Officer | SVP &General Counsel
1 company
Insider Signal Score
58
GoodTrades Analyzed
21
12M Win Rate
47.4%
Avg 3M Return
-3.7%
Avg 12M Return
-8.4%
Wilson Mark Andrew is a Chief Legal Officer at NEKTAR THERAPEUTICS. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $1.4M based on current market prices.
Holdings by Company
NKTRNov 25, 2025
Current Shares21.6K
Value$1.40M
Net Activity-169,627
Bought: 0Sold: 169.6K
Transaction History
Showing 10 filings (page 2)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 | NKTR Nektar Therapeutics | Chief Legal Officer | Sell | 7,221 | $0.78 | $5,632.38 | -2.8% | -33.6% | +54.9% | |
| May 16, 2023 | NKTR Nektar Therapeutics | Chief Legal Officer | Sell | 7,543 | $0.72 | $5,430.96 | -2.8% | +15.2% | +155.9% | |
| Feb 16, 2023 | NKTR Nektar Therapeutics | Chief Legal Officer | Sell | 8,275 | $3.00 | $24,825.00 | -3.0% | -76.5% | -76.1% | |
| Nov 16, 2022 | NKTR Nektar Therapeutics | Chief Legal Officer | Sell | 8,690 | $3.57 | $31,023.30 | -3.1% | -14.2% | -85.7% | |
| Aug 16, 2022 | NKTR Nektar Therapeutics | SVP &General Counsel | Sell | 3,189 | $4.76 | $15,179.64 | -1.1% | -12.8% | -83.6% | |
| May 16, 2022 | NKTR Nektar Therapeutics | SVP &General Counsel | Sell | 3,136 | $3.95 | $12,387.20 | -2.6% | +26.5% | -81.6% | |
| Feb 16, 2022 | NKTR Nektar Therapeutics | SVP &General Counsel | Sell | 3,661 | $10.95 | $40,087.95 | -2.9% | -64.8% | -73.4% | |
| Nov 16, 2021 | NKTR Nektar Therapeutics | SVP &General Counsel | Sell | 6,564 | $13.16 | $86,382.24 | -7.1% | -18.3% | -73.5% | |
| Aug 16, 2021 | NKTR Nektar Therapeutics | SVP &General Counsel | Sell | 1,910 | $13.83 | $26,415.30 | -2.6% | -3.1% | -66.0% | |
| May 17, 2021 | NKTR Nektar Therapeutics | SVP &General Counsel | Sell | 1,917 | $18.30 | $35,081.10 | -2.5% | -24.3% | -78.3% |